Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome

American Journal of Hypertension

Volumn 26, Issue 12, 2013, Pages 1377-1380

  Miranda, Maria L ^a   Macher, Hada C ^b   Muñoz Hernández, Rocio ^a   Vallejo Vaz, Antonio ^a   Moreno Luna, Rafael ^a   Villar, Jose ^a   Guerrero, Juan M ^b   Stiefel, Pablo ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Blood pressure; HELLP syndrome; Hypertension; Hypertension in pregnancy; Hypertensive disorders of pregnancy; Preeclampsia

Indexed keywords

CELL DNA;

ADULT; ARTICLE; CELL FREE SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HELLP SYNDROME; HUMAN; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 84890493298     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt187     Document Type: Article

References (18)

1. Shimony A, Zahger D, Gilutz H, Goldstein H, Orlov G, Merkin M, Shalev A, Ilia R, Douvdevani A. Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients. Acute Card Care 2010; 12:109-111.
2. Zaravinos A, Tzoras S, Apostolakis S, Lazaridis K, Spandidos DA. Levosimendan reduces plasma cell-free DNA levels in patients with ischemic cardiomyopathy. J Thromb Thrombolysis 2011; 31:180-187.
3. Tsai NW, Lin TK, Chen SD, Chang WN, Wang HC, Yang TM, Lin YJ, Jan CR, Huang CR, Liou CW, Lu CH. The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke. Clin Chim Acta 2011; 412:476-479.
4. Arnalich F, Maldifassi MC, Ciria E, Quesada A, Codoceo R, Herruzo R, Garcia-Cerrada C, Montoya F, Vazquez JJ, López-Collazo E, Montiel C. Association of cell-free plasma DNA with perioperative mortality in patients with suspected acute mesenteric ischemia. Clin Chim Acta 2010; 411:1269-1274.
5. Huang CH, Tsai MS, Hsu CY, Chen HW, Wang TD, Chang WT, Ma MH, Chien KL, Chen SC, Chen WJ. Circulating cell-free DNA levels correlate with postresuscitation survival rates in out-of-hospital cardiac arrest patients. Resuscitation 2011; 83:213-218.
6. Uzuelli JA, Dias-Junior CA, Izidoro-Toledo TC, Gerlach RF, Tanus-Santos JE. Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism. Clin Chim Acta 2009; 409:112-116.
7. Ye L, Ma GH, Chen L, Li M, Liu JL, Yang K, Li QY, Li N, Wan HY. Quantification of circulating cell-free DNA in the serum of patients with obstructive sleep apnea-hypopnea syndrome. Lung 2010; 188:469-474.
8. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol 2010; 5:173-192.
9. Hahn S, Rusterholz C, Hösli I, Lapaire O. Cell-free nucleic acids as potential markers for preeclampsia. Placenta 2011; 32:S17-S20.
10. Lázár L, Nagy B, Molvarec A, Rigó J Jr. Quantity of total cell free and cell free fetal DNA in pregnancies with no complications and with preeclampsia. Orv Hetil 2010; 151:784-787.
11. Lázár L, Rigó J Jr, Nagy B, Balogh K, Makó V, Cervenak L, Mézes M, Prohászka Z, Molvarec A. Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Med Genet 2009; 10:120.
12. Vallejo Maroto I, Miranda Guisado ML, Stiefel García-Junco P, Pamies Andreu E, Marenco ML, Castro de Gavilan D, Carneado de la Fuente J. Clinical and biological characteristics of a group of 54 pregnant women with HELLP syndrome. Med Clin (Barc) 2004; 122:259-261.
13. Miranda ML, Vallejo A, Villar J, Cerrillo L, Marenco ML, Stiefel P. The syndrome of hemolysis, elevated liver enzymes and low platelet count (HELLP syndrome): clinical characteristics and maternal-fetal outcome in a series of 172 consecutive patients. Pregnancy Hypertens 2011; 1:164-169.
14. Hadad B, Barton JR, Livingston JC, Chahine R, Sibai BM. Risk factor for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000; 183:444-448.
15. Roelofsen AC, van Pampus MG, Aarnoudse JG. The HELLP-syndrome: maternal-fetal outcome and follow up of infants. J Perinat Med 2003; 31:201-208.
16. Vallejo-Vaz AJ, Stiefel P, Alfaro V, Miranda ML. Isolated abducens nerve palsy in preeclampsia and hypertension in pregnancy. Hypertens Res 2013;36:834-835.
17. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?. Am J Obstet Gynecol 1990; 162:311-316.
18. D'Ana R. The HELLP syndrome. Notes on its pathogenesis and treatment. Minerva Ginecol 1996; 48:147-154.